(19)
(11)
EP 1 165 093 A1
(12)
(43)
Date of publication:
02.01.2002
Bulletin 2002/01
(21)
Application number:
00913730.8
(22)
Date of filing:
02.03.2000
(51)
International Patent Classification (IPC)
7
:
A61K
31/70
,
A61K
48/00
,
A61K
49/00
,
C07H
21/00
,
C12N
15/63
(86)
International application number:
PCT/US0005/643
(87)
International publication number:
WO 0051/621
(
08.09.2000
Gazette 2000/36)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
05.03.1999
US 122950 P
(71)
Applicant:
Epigenesis Pharmaceuticals, Inc.
Cranbury, NJ 08520 (US)
(72)
Inventor:
NYCE, Jonathan, W.
Princeton, NY 08540 (US)
(74)
Representative:
Becker Kurig Straus
Patentanwälte Bavariastrasse 7
80336 München
80336 München (DE)
(54)
METHOD FOR VALIDATING/INVALIDATING TARGET(S) AND PATHWAYS